Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6.5M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 12 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| May 7 | ODTX | Odyssey Therapeutics, Inc. | AGRANT◆ | 27,393 | — | — | — | Open the original filing on SEC.gov |
| Feb 25 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 260 | $486.35 | $126.5K | -0.5% | Open the original filing on SEC.gov |
| Feb 24 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 1,627 | $485.11 | $789.3K | -3.3% | Open the original filing on SEC.gov |
| Feb 18 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 368 | $473.68 | $174.3K | -0.8% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 609 | $489.46 | $298.1K | -1.2% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 2,294 | $483.75 | $1.1M | -4.4% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT◷ | 5,789 | — | — | +12.6% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,500 | $499.99 | $750K | -3.1% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 3,804 | $487.76 | $1.9M | -7.4% | Open the original filing on SEC.gov |
| Feb 11 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 466 | $460.43 | $214.6K | -0.9% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 2,140 | $468.41 | $1M | -4.0% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 3,883 | — | — | +7.7% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 7,866 | — | — | +18.6% | Open the original filing on SEC.gov |
| Jan 7 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 4,500 | $474.99 | $2.1M | -9.6% | Open the original filing on SEC.gov |
| Dec 3, 2025 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 4,500 | $449.99 | $2M | -8.8% | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 42,200 | — | — | — | Open the original filing on SEC.gov |
| Jul 25, 2025 | VERV | Verve Therapeutics, Inc. | DTOISS◆ | 267,541 | — | — | — | Open the original filing on SEC.gov |
| Jun 5, 2025 | VERV | Verve Therapeutics, Inc. | AGRANT◆ | 42,200 | — | — | — | Open the original filing on SEC.gov |